These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18375418)

  • 1. Global coronary heart disease risk assessment of individuals with the metabolic syndrome in the U.S.
    Hoang KC; Ghandehari H; Lopez VA; Barboza MG; Wong ND
    Diabetes Care; 2008 Jul; 31(7):1405-9. PubMed ID: 18375418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of coronary heart disease risk assessments among individuals with metabolic syndrome using three diagnostic definitions: a cross-sectional study from China.
    Zhou J; Gao Q; Wang J; Zhang M; Ma J; Wang C; Chen H; Peng X; Hao L
    BMJ Open; 2018 Oct; 8(10):e022974. PubMed ID: 30366915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older.
    Alexander CM; Landsman PB; Teutsch SM; Haffner SM; ;
    Diabetes; 2003 May; 52(5):1210-4. PubMed ID: 12716754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies.
    Meigs JB; Wilson PW; Nathan DM; D'Agostino RB; Williams K; Haffner SM
    Diabetes; 2003 Aug; 52(8):2160-7. PubMed ID: 12882936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study.
    Sattar N; Gaw A; Scherbakova O; Ford I; O'Reilly DS; Haffner SM; Isles C; Macfarlane PW; Packard CJ; Cobbe SM; Shepherd J
    Circulation; 2003 Jul; 108(4):414-9. PubMed ID: 12860911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey.
    Ko M; Kim MT; Nam JJ
    Int J Cardiol; 2006 Jun; 110(2):184-90. PubMed ID: 16412525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of coronary heart disease risk among four diagnostic definitions of metabolic syndrome.
    Suzuki T; Zeng Z; Zhao B; Wei Z; Tanabe M; Shimbo T; Kajio H; Kato N; Naruse M
    J Endocrinol Invest; 2016 Nov; 39(11):1337-1346. PubMed ID: 27572249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus.
    Wilson PW; D'Agostino RB; Parise H; Sullivan L; Meigs JB
    Circulation; 2005 Nov; 112(20):3066-72. PubMed ID: 16275870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein.
    Malik S; Wong ND; Franklin S; Pio J; Fairchild C; Chen R
    Diabetes Care; 2005 Mar; 28(3):690-3. PubMed ID: 15735209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
    Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of multiple cardiac risk factors in US adults with diabetes.
    McCollum M; Ellis SL; Morrato EH; Sullivan PW
    Curr Med Res Opin; 2006 Jun; 22(6):1031-4. PubMed ID: 16846537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of metabolic syndrome by the Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions and their association with coronary heart disease in an elderly Iranian population.
    Hadaegh F; Zabetian A; Tohidi M; Ghasemi A; Sheikholeslami F; Azizi F
    Ann Acad Med Singap; 2009 Feb; 38(2):142-9. PubMed ID: 19271043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight, the metabolic syndrome, and coronary heart disease in type 2 diabetes: associations among a national French sample of adults with diabetes-the ENTRED study.
    Hillier TA; Fosse S; Balkau B; Simon D; Eschwège E; Fagot-Campagna A
    J Cardiometab Syndr; 2006; 1(5):318-25. PubMed ID: 17679788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
    Lakka HM; Laaksonen DE; Lakka TA; Niskanen LK; Kumpusalo E; Tuomilehto J; Salonen JT
    JAMA; 2002 Dec; 288(21):2709-16. PubMed ID: 12460094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The distribution of 10-Year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III.
    Ford ES; Giles WH; Mokdad AH
    J Am Coll Cardiol; 2004 May; 43(10):1791-6. PubMed ID: 15145101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in predicted 10-year risk of coronary heart disease and cardiovascular disease among U.S. adults from 1999 to 2010.
    Ford ES
    J Am Coll Cardiol; 2013 Jun; 61(22):2249-52. PubMed ID: 23563124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical usefulness of the metabolic syndrome for the risk of coronary heart disease does not exceed the sum of its individual components in older men and women. The Three-City (3C) Study.
    Rachas A; Raffaitin C; Barberger-Gateau P; Helmer C; Ritchie K; Tzourio C; Amouyel P; Ducimetière P; Empana JP
    Heart; 2012 Apr; 98(8):650-5. PubMed ID: 22505463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative importance of borderline and elevated levels of coronary heart disease risk factors.
    Vasan RS; Sullivan LM; Wilson PW; Sempos CT; Sundström J; Kannel WB; Levy D; D'Agostino RB
    Ann Intern Med; 2005 Mar; 142(6):393-402. PubMed ID: 15767617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicted coronary risk for adults with coronary heart disease and low HDL-C: an analysis from the US National Health and Nutrition Examination Survey.
    Zhang B; Menzin J; Friedman M; Korn JR; Burge RT
    Curr Med Res Opin; 2008 Sep; 24(9):2711-7. PubMed ID: 18701005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.